GO:0042699 follicle-stimulating hormone signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042699 describes the G protein-coupled receptor signaling pathway initiated by follicle-stimulating hormone (FSH) binding to its receptor (FSHR) on target cells.
• FSH signaling is essential for gonadal function, including Sertoli cell support of spermatogenesis and ovarian granulosa cell proliferation and differentiation.
• The pathway involves ligand binding, receptor activation, G protein coupling, and downstream regulation of cellular processes such as gene expression and steroidogenesis.
• Biased signaling by FSH variants can differentially activate pathways, influencing physiological outcomes.
• FSH signaling has been implicated in cancer progression, metabolic regulation, and reproductive disorders.
• Research tools include CRISPR knockout, knock-in, overexpression models, and high-throughput screening to dissect pathway components.
Description
The follicle-stimulating hormone signaling pathway (GO:0042699) is a biological process that begins with FSH binding to its receptor on the surface of target cells and culminates in the regulation of downstream cellular responses. This pathway is a classic example of G protein-coupled receptor (GPCR) signaling and is central to reproductive biology, influencing gametogenesis, steroidogenesis, and follicular development. Dysregulation of FSH signaling is associated with infertility, gonadal dysfunction, and certain cancers, making it a key area of biomedical research. Understanding the molecular mechanisms of this pathway is essential for developing therapeutic interventions and for interpreting genetic variants that affect reproductive health. This article synthesizes current knowledge from authoritative sources and provides a framework for studying GO:0042699 using modern experimental approaches.
follicle-stimulating hormone signaling pathway At A Glance
| GO ID | GO:0042699 |
|---|---|
| GO term | follicle-stimulating hormone signaling pathway |
| Ontology | biological_process |
| Synonym | follicle stimulating hormone signaling pathway; follicle stimulating hormone signalling pathway; follicle-stimulating hormone signalling pathway |
| Major function | Transduces FSH signals from the cell surface to regulate gene expression, steroidogenesis, cell proliferation, and differentiation in gonadal tissues. |
| Ligand | Follicle-stimulating hormone (FSH), a heterodimeric glycoprotein hormone. |
| Receptor | Follicle-stimulating hormone receptor (FSHR), a G protein-coupled receptor. |
| Tissue distribution | Primarily expressed in gonadal tissues: Sertoli cells in testes and granulosa cells in ovaries. |
| Downstream effectors | G proteins (Gs, Gq), adenylyl cyclase, cAMP, PKA, and other signaling cascades. |
What Is GO:0042699?
According to the Gene Ontology, GO:0042699 (follicle-stimulating hormone signaling pathway) is defined as a G protein-coupled receptor signaling pathway initiated by follicle-stimulating hormone binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. This definition encompasses the series of molecular events from ligand-receptor interaction to intracellular signal transduction and ultimate cellular response.
Why Is follicle-stimulating hormone signaling pathway Important in Cell Biology?
The FSH signaling pathway is indispensable for mammalian reproduction. It regulates the development and function of gonads, including spermatogenesis in males and folliculogenesis in females. Beyond reproduction, FSH signaling has been implicated in metabolic regulation, such as glucose-stimulated insulin secretion, and in cancer progression. Understanding this pathway at the molecular level is crucial for diagnosing and treating reproductive disorders, and for developing targeted therapies.
• Essential for spermatogenesis: FSH signaling in Sertoli cells supports the early stages of sperm production.
• Critical for folliculogenesis: FSH drives granulosa cell proliferation and differentiation, and oocyte maturation.
• Regulates steroidogenesis: FSH modulates the production of estrogens and progestins in the ovary.
• Implicated in cancer: Aberrant FSH signaling is associated with ovarian and other cancers.
• Influences metabolism: FSH signaling can affect glucose-stimulated insulin secretion from pancreatic islets.
• Biased signaling: Different FSH variants can preferentially activate distinct downstream pathways, affecting physiology.
• Therapeutic target: FSHR is a target for fertility treatments and potential contraceptives.
• Genetic variants: Polymorphisms in FSHR can alter signaling and are linked to reproductive disorders.
• Model for GPCR research: FSH signaling serves as a paradigm for understanding GPCR function and biased agonism.
• Epigenetic regulation: Post-translational modifications, such as lactylation of CREB, are involved in FSH-induced gene expression.
What Happens During follicle-stimulating hormone signaling pathway?
Ligand Binding and Receptor Activation
In simple terms: FSH binds to its receptor on the cell surface, like a key fitting into a lock.
The pathway begins when follicle-stimulating hormone (FSH) binds to the follicle-stimulating hormone receptor (FSHR), a G protein-coupled receptor (GPCR) located on the surface of target cells such as granulosa cells and Sertoli cells. This binding induces a conformational change in FSHR, leading to its activation. FSHR is characterized by a large extracellular domain that confers ligand specificity and a transmembrane domain typical of GPCRs. The binding affinity and specificity are critical for initiating the signaling cascade.
G Protein Coupling and Effector Activation
In simple terms: The activated receptor turns on G proteins, which then activate enzymes to produce messenger molecules.
Upon activation, FSHR interacts with heterotrimeric G proteins, primarily Gs, which stimulates adenylyl cyclase to produce cyclic AMP (cAMP). This leads to activation of protein kinase A (PKA) and subsequent phosphorylation of downstream targets. FSHR can also couple to other G proteins, such as Gq, leading to phospholipase C activation and calcium mobilization. The specific G protein coupling can be influenced by ligand variants and receptor modifications, contributing to biased signaling.
Downstream Signaling Cascades
In simple terms: The signal spreads inside the cell, turning on many proteins that change cell behavior.
The increase in cAMP activates PKA, which phosphorylates transcription factors such as CREB, leading to changes in gene expression. Additionally, FSH signaling activates the MAPK/ERK pathway, PI3K/AKT pathway, and other cascades that regulate cell proliferation, differentiation, and survival. In ovarian granulosa cells, FSH-induced signaling promotes cell cycle progression and the expression of genes involved in steroidogenesis and follicular development. In Sertoli cells, FSH signaling supports the early stages of spermatogenesis by regulating gene expression and cell adhesion.
Regulation of Cellular Processes
In simple terms: The final outcome is that the cell changes what it does, such as growing, dividing, or making hormones.
The ultimate effects of FSH signaling include regulation of cell proliferation, differentiation, apoptosis, and steroid hormone production. In the ovary, FSH stimulates granulosa cell proliferation and the expression of aromatase, which converts androgens to estrogens. In the testis, FSH promotes Sertoli cell function and supports spermatogenesis. Dysregulation of these processes can lead to reproductive disorders and cancers. The pathway is tightly regulated by feedback mechanisms, including hormonal feedback and receptor desensitization.
Biased Signaling and Variants
In simple terms: Different forms of FSH can activate different sets of signals, leading to diverse outcomes.
Recent research has revealed that human FSH variants can exhibit biased signaling, preferentially activating certain downstream pathways over others. This biased signaling can have distinct physiological consequences, such as differential effects on cAMP production versus ERK activation. Understanding biased signaling is important for drug development, as it may allow for the design of ligands that selectively activate beneficial pathways while avoiding adverse effects.
Key Genes Involved in GO:0042699 follicle-stimulating hormone signaling pathway
The following genes and proteins are key components of the follicle-stimulating hormone signaling pathway, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FSHR | Receptor for FSH; initiates signaling | Mutations cause ovarian dysgenesis and spermatogenic failure; target for fertility drugs |
| FSHB | Beta subunit of FSH; confers specificity | Mutations lead to hypogonadism; used in recombinant FSH production |
| CGA | Alpha subunit of FSH; common to glycoprotein hormones | Essential for FSH assembly and secretion |
| GNAS | Gs alpha subunit; couples FSHR to adenylyl cyclase | Mutations cause pseudohypoparathyroidism and affect FSH signaling |
| ADCY | Adenylyl cyclase; produces cAMP | Isoforms differentially expressed in gonads; modulate FSH response |
| PRKACA | Catalytic subunit of PKA; phosphorylates targets | Mutations in adrenal Cushing's; role in FSH signaling |
| CREB1 | Transcription factor activated by PKA; regulates gene expression | Lactylation required for FSH-induced granulosa cell proliferation |
| MAPK1/3 | ERK kinases; regulate proliferation and differentiation | Activated by FSH in granulosa and Sertoli cells |
| AKT1 | PI3K/AKT pathway; promotes survival and growth | Mediates FSH-induced granulosa cell proliferation |
| AR | Androgen receptor; interacts with FSH signaling | Modulates folliculogenesis and steroidogenesis |
| ESR1/2 | Estrogen receptors; mediate feedback and meiotic arrest | E2/ER signaling mediates FSH-induced meiotic arrest in oocytes |
| CYP19A1 | Aromatase; converts androgens to estrogens | Induced by FSH in granulosa cells; key for estrogen production |
| INHBA | Inhibin beta A subunit; feedback regulator | Inhibin inhibits FSH secretion; expressed in gonads |
| AMH | Anti-Mullerian hormone; regulates follicle recruitment | Modulated by FSH; marker of ovarian reserve |
| LHCGR | LH receptor; cooperates with FSHR in folliculogenesis | Induced by FSH in granulosa cells; essential for ovulation |
| GDF9 | Growth differentiation factor 9; oocyte-derived | Regulates granulosa cell function in concert with FSH |
| BMP15 | Bone morphogenetic protein 15; oocyte-derived | Modulates FSH responsiveness in granulosa cells |
| KITLG | Kit ligand; paracrine factor | Promotes oocyte growth and follicular development with FSH |
How Is follicle-stimulating hormone signaling pathway Regulated?
The FSH signaling pathway is subject to multiple layers of regulation. At the receptor level, FSHR expression is regulated by hormones and local factors, and receptor desensitization occurs via phosphorylation and arrestin recruitment. Intracellularly, signaling is modulated by phosphatases, phosphodiesterases that degrade cAMP, and feedback loops involving CREB and other transcription factors. Post-translational modifications, such as lactylation of CREB, have been shown to be required for FSH-induced proliferation and differentiation of ovarian granulosa cells. Additionally, biased signaling by FSH variants can differentially regulate downstream effectors. Extracellularly, FSH secretion is controlled by GnRH and feedback from gonadal steroids and inhibin.
follicle-stimulating hormone signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FSHR | Ovarian dysgenesis, spermatogenic failure, ovarian hyperstimulation syndrome | Knockout mouse, patient-derived iPSCs, knock-in of patient mutations |
| FSHB | Hypogonadism, infertility | Knockout mouse, overexpression in cell lines |
| CGA | Hypogonadism, isolated FSH deficiency | Knockout mouse, CRISPR knock-in |
| GNAS | Pseudohypoparathyroidism, Albright hereditary osteodystrophy | Conditional knockout, point mutation knock-in |
| CREB1 | Reproductive disorders, cancer | Knockout, point mutation (lactylation sites), overexpression |
Reproductive Disorders
Mutations in FSHR or FSHB can lead to reproductive disorders such as ovarian dysgenesis, premature ovarian failure, and spermatogenic failure. In women, inactivating FSHR mutations cause hypergonadotropic hypogonadism and infertility. Activating mutations are rare but can cause ovarian hyperstimulation syndrome. Polymorphisms in FSHR, such as Asn680Ser, have been associated with variable responses to controlled ovarian stimulation.
Cancer
Aberrant FSH signaling has been implicated in the progression of gynecological cancers, including ovarian and endometrial cancers. FSHR is overexpressed in many ovarian cancers, and FSH can promote cancer cell proliferation and survival. Targeting FSHR with antibodies or small molecule inhibitors is being explored as a therapeutic strategy. Additionally, FSH signaling may influence other cancers, such as pancreatic cancer, through metabolic effects.
Metabolic Regulation
Recent studies have revealed a role for FSH signaling in metabolic regulation. FSH orchestrates glucose-stimulated insulin secretion from pancreatic islets, suggesting a link between reproductive hormones and glucose homeostasis. This cross-talk may have implications for conditions such as polycystic ovary syndrome (PCOS) and type 2 diabetes. Further research is needed to fully understand the mechanisms involved.
From follicle-stimulating hormone signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FSHR mediate FSH-induced granulosa cell proliferation? | FSHR knockout granulosa cell line (e.g., KGN) via CRISPR |
| What is the effect of a specific FSHR mutation on cAMP production? | Point mutation knock-in in HEK293 cells expressing mutant FSHR |
| How does FSH variant biased signaling affect ERK activation? | Knock-in of FSH variant in cell line, phospho-ERK assays |
| Is CREB lactylation required for FSH-induced gene expression? | Point mutation of CREB lactylation sites via CRISPR knock-in |
| Can overexpression of constitutively active FSHR mimic FSH signaling? | Overexpression of mutant FSHR in granulosa cells |
| What genes are regulated by FSH in Sertoli cells? | RNA-seq after FSH treatment in wild-type and FSHR knockout Sertoli cells |
How to Study the follicle-stimulating hormone signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify FSH-regulated genes in granulosa cells |
| Phosphoproteomics | Phosphorylation events | Map signaling networks downstream of FSHR |
| CRISPR knockout screen | Loss-of-function effects on pathway | Discover novel regulators of FSH signaling |
| FRET biosensors | Real-time cAMP/PKA activity | Monitor signaling dynamics in live cells |
| Western blot | Protein expression and phosphorylation | Validate specific pathway activation |
| Immunofluorescence | Protein localization and expression | Visualize FSHR and downstream effectors |
| Reporter assays | Transcriptional activity | Measure CREB-driven gene expression |
| Flow cytometry | Cell proliferation and apoptosis | Assess FSH effects on cell cycle |
Transcriptomics and RNA-seq
RNA sequencing can identify global changes in gene expression following FSH stimulation. This method is useful for uncovering downstream targets of the pathway and for comparing wild-type and mutant cells. For example, RNA-seq in granulosa cells treated with FSH reveals induction of genes involved in steroidogenesis and proliferation.
Phosphoproteomics
Phosphoproteomics allows comprehensive analysis of phosphorylation events downstream of FSHR activation. This technique can identify novel substrates of PKA and other kinases activated by FSH. It is particularly useful for understanding biased signaling and for mapping signaling networks.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate FSH signaling. For example, a screen for regulators of FSH-induced proliferation could uncover novel components. This approach is powerful for unbiased discovery of pathway modulators.
Imaging and Live-Cell Assays
Fluorescence resonance energy transfer (FRET) biosensors can monitor cAMP and PKA activity in live cells upon FSH stimulation. Confocal microscopy can visualize FSHR internalization and trafficking. These methods provide spatiotemporal insights into signaling dynamics.
How CRISPR Can Be Used to Study GO:0042699 follicle-stimulating hormone signaling pathway
Knockout
CRISPR knockout of FSHR or downstream effectors (e.g., GNAS, CREB1) can abolish FSH signaling, providing a clean background to study pathway requirements. For example, FSHR knockout granulosa cells fail to proliferate in response to FSH, confirming the receptor's essential role. Knockout models are also useful for identifying compensatory mechanisms.
Point Mutation
Introducing specific point mutations via CRISPR (e.g., in FSHR or CREB1) allows functional dissection of individual residues. For instance, mutation of CREB lactylation sites can test their requirement for FSH-induced gene expression. Point mutations can also model human disease variants, such as FSHR Asn680Ser, to study their impact on signaling.
Knock-in
Knock-in of tagged or reporter genes (e.g., GFP-FSHR) enables live-cell imaging and protein interaction studies. Knock-in of disease-associated mutations into the endogenous locus provides physiologically relevant models. For example, knocking in a constitutively active FSHR mutation can mimic ovarian hyperstimulation syndrome.
Overexpression
Overexpression of wild-type or mutant FSHR, FSH subunits, or downstream effectors can amplify signaling and reveal gain-of-function phenotypes. This approach is useful for studying biased signaling by FSH variants and for producing recombinant proteins for structural studies.
How EDITGENE Supports follicle-stimulating hormone signaling pathway Research
Researchers studying follicle-stimulating hormone signaling pathway-related genes often need to determine whether a candidate gene is causally involved in the pathway, and to dissect its precise function using robust genetic models. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for follicle-stimulating hormone signaling pathway research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CGA Knockout HEK293 Cell Line | EDJ-KQ1760 | Human | 1081 | Details Get a Quote |
| FSHR Knockout HEK293 Cell Line | EDJ-KQ1776 | Human | 2492 | Details Get a Quote |
| CGA Knockout HeLa Cell Line | EDJ-KQ21637 | Human | 1081 | Details Get a Quote |
| FSHB Knockout HEK293 Cell Line | EDJ-KQ50283 | Human | 2488 | Details Get a Quote |
| FSHB Knockout HeLa Cell Line | EDJ-KQ53268 | Human | 2488 | Details Get a Quote |
| FSHR Knockout HeLa Cell Line | EDJ-KQ53269 | Human | 2492 | Details Get a Quote |
| CGA Knockout A-549 Cell Line | EDJ-KQ61350 | Human | 1081 | Details Get a Quote |
| FSHB Knockout A-549 Cell Line | EDJ-KQ61751 | Human | 2488 | Details Get a Quote |
| FSHR Knockout A-549 Cell Line | EDJ-KQ61752 | Human | 2492 | Details Get a Quote |
| CGA Knockout HCT 116 Cell Line | EDJ-KQ69844 | Human | 1081 | Details Get a Quote |
| FSHB Knockout HCT 116 Cell Line | EDJ-KQ70235 | Human | 2488 | Details Get a Quote |
| FSHR Knockout HCT 116 Cell Line | EDJ-KQ70236 | Human | 2492 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About follicle-stimulating hormone signaling pathway
What is the follicle-stimulating hormone signaling pathway?
It is a biological process (GO:0042699) where FSH binds to its receptor on target cells, triggering a G protein-coupled receptor signaling cascade that regulates downstream cellular responses.
What genes are involved in follicle-stimulating hormone signaling pathway?
Key genes include FSHR (receptor), FSHB and CGA (hormone subunits), GNAS (G protein), ADCY (adenylyl cyclase), PRKACA (PKA), CREB1 (transcription factor), and MAPK1/3 (kinases).
How does FSH signaling work?
FSH binds to FSHR, activating G proteins that stimulate adenylyl cyclase to produce cAMP, which activates PKA and other pathways, leading to changes in gene expression and cell behavior.
What are the downstream effects of FSH signaling?
Downstream effects include granulosa cell proliferation and differentiation, steroidogenesis, oocyte maturation, and Sertoli cell support of spermatogenesis.
What diseases are associated with FSH signaling?
Mutations in FSHR cause ovarian dysgenesis and spermatogenic failure; aberrant signaling is implicated in ovarian cancer and metabolic disorders.
How can I study FSH signaling using CRISPR?
CRISPR can be used to knockout FSHR or downstream genes, introduce point mutations to model disease variants, knock-in tags for imaging, or overexpress components to study gain-of-function.
What is biased signaling in FSH pathway?
Biased signaling refers to the ability of different FSH variants to preferentially activate certain downstream pathways over others, leading to distinct physiological outcomes.
What cell models are used for FSH signaling research?
Common models include granulosa cell lines (e.g., KGN, COV434), Sertoli cell lines (e.g., TM4), HEK293 cells expressing recombinant FSHR, and primary cells from knockout mice.
How is FSH signaling regulated?
It is regulated by receptor desensitization, phosphodiesterases, phosphatases, feedback from gonadal steroids and inhibin, and post-translational modifications such as CREB lactylation.
What are the therapeutic implications of FSH signaling?
FSHR is a target for fertility drugs and contraceptives; inhibitors are being explored for cancer therapy; understanding biased signaling may lead to safer drugs.
Conclusion
The follicle-stimulating hormone signaling pathway (GO:0042699) is a fundamental biological process that governs reproductive function and has broader implications in metabolism and cancer. Advances in CRISPR technology and high-throughput methods are enabling detailed dissection of this pathway, from ligand-receptor interactions to downstream gene regulation. Continued research will uncover new therapeutic targets and improve our understanding of reproductive health and disease.
References
- 1. Cheng Y et al.. 2023. Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets.. Nat Commun 14(1):6991 PMID: 37914684
- 2. Wang JM et al.. 2022. Follicle-stimulating hormone signaling in Sertoli cells: a licence to the early stages of spermatogenesis.. Reprod Biol Endocrinol 20(1):97 PMID: 35780146
- 3. Ulloa-Aguirre A et al.. 2025. Biased signaling by human follicle-stimulating hormone variants.. Pharmacol Ther 268:108821 PMID: 39961417
- 4. Hsueh AJ et al.. 2015. Intraovarian control of early folliculogenesis.. Endocr Rev 36(1):1-24 PMID: 25202833
- 5. Li Y et al.. 2026. Follicle-stimulating hormone and cancer.. Cell Signal 147:112738 PMID: 42442675
- 6. Wu G et al.. 2025. Lactylation of CREB is required for FSH-induced proliferation and differentiation of ovarian granulosa cells.. Nucleic Acids Res 53(17) PMID: 40966521
- 7. De Pascali F et al.. 2018. Follicle-Stimulating Hormone Receptor: Advances and Remaining Challenges.. Int Rev Cell Mol Biol 338:1-58 PMID: 29699689
- 8. Lu S et al.. 2023. E2/ER signaling mediates the meiotic arrest of goat intrafollicular oocytes induced by follicle-stimulating hormone.. J Anim Sci 101 PMID: 37925610
